v3.26.3
Stockholders' Equity and Warrants - Additional Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 26, 2026
Dec. 15, 2025
Nov. 10, 2025
Jun. 25, 2025
Dec. 27, 2024
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Class of Stock [Line Items]                  
Aggregate net proceeds               $ 48,396,000 $ 20,257,000
Change in fair value of warrant liabilities           $ 32,890,000 $ 790,457,000 240,549,000 2,090,379,000
Stock issuance cost               $ 234,000 $ 1,194,000
2025 PIPE Warrants                  
Class of Stock [Line Items]                  
Amount of warrant issued       $ 175,000,000          
RemeGen Warrant                  
Class of Stock [Line Items]                  
Amount of warrant issued       177,400,000          
2024 Warrants                  
Class of Stock [Line Items]                  
Exercise price of warrants           $ 0   $ 0  
2025 Warrants                  
Class of Stock [Line Items]                  
Warrants exercised           $ 4,350,000,000   $ 14,748,099,000  
Warrants outstanding           $ 31,172,260,000   31,172,260,000  
Change in fair value of warrant liabilities               $ 594,700,000  
Private Placement                  
Class of Stock [Line Items]                  
Aggregate net proceeds       $ 174,400,000 $ 52,700,000        
Exercise price of warrants       $ 0.002 $ 16.76        
Warrants expiration period         7 years        
Warrants expiration date         Dec. 30, 2031        
Common Stock | RemeGen Warrant                  
Class of Stock [Line Items]                  
Warrants purchase       16,000,000          
Common Stock | Private Placement                  
Class of Stock [Line Items]                  
Common stock shares sold   13,876,032     2,793,562        
Warrants purchase       34,999,999 3,491,953        
Aggregate net proceeds   $ 149,900,000              
Common stock issued price per share   $ 10.81              
Common Stock | Private Placement | TCGX                  
Class of Stock [Line Items]                  
Common stock shares sold 5,338,078                
Aggregate net proceeds $ 74,900,000                
Common stock issued price per share $ 14.05                
Common Stock | November 2025 Public Offering                  
Class of Stock [Line Items]                  
Common stock shares sold     11,500,000            
Aggregate net proceeds     $ 107,700,000            
Common stock issued price per share     $ 10            
Common Stock | 30day Option to Purchase Additional Shares Under November 2025 Offering                  
Class of Stock [Line Items]                  
Common stock shares sold     1,500,000            
At-the-Market Sales                  
Class of Stock [Line Items]                  
Common stock shares sold           2,558,569      
Aggregate gross proceeds           $ 48,900,000      
Commissions           $ 500,000      
Weighted average price per share           $ 19.11   $ 19.11  
Remaining capacity under prospectus supplement           $ 0